Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News Aethlon Medical Inc AEMD

Healthcare Medical Devices

Aethlon Medical, Inc. is a medical therapeutic company focused on developing the Hemopurifier, a clinical-stage immunotherapeutic device which is designed to combat cancer and life-threatening viral infections and for use in organ transplantation. The Hemopurifier, in pre-clinical studies, has demonstrated the removal of harmful exosomes from biological fluids, utilizing its lectin-based... see more

Add To Watchlist

Recent & Breaking News (NDAQ:AEMD)

Aethlon Announces Appointment of Charles J. Fisher, Jr., M.D. as Chief Executive Officer

PR Newswire November 3, 2020

Aethlon Medical Announces Second Quarter Financial Results and Provides Corporate Update

PR Newswire October 28, 2020

Aethlon Medical To Release Second Quarter Financial Results and Host Conference Call on October 28, 2020

PR Newswire October 19, 2020

Aethlon Medical to Present at the H.C. Wainwright 22nd Annual Global Investment Conference

PR Newswire September 9, 2020

Aethlon Medical to Present at the LD Micro 500 Virtual Conference

PR Newswire August 27, 2020

Aethlon Medical Announces First Quarter Financial Results and Provides Corporate Update

PR Newswire August 11, 2020

Aethlon Medical Announces Collaboration with University of Pittsburgh on NIH Grant for Head and Neck Cancer

PR Newswire August 6, 2020

Aethlon Medical To Release First Quarter Financial Results and Host Conference Call on August 11, 2020

PR Newswire August 4, 2020

Aethlon Medical Announces Fiscal Year Financial Results and Provides Corporate Update

PR Newswire June 25, 2020

Aethlon Medical Presents Hemopurifier® Data at the American Association for Cancer Research 2020 Annual Meeting

PR Newswire June 22, 2020

Aethlon Announces FDA Approval of IDE Supplement for COVID-19 Patients

PR Newswire June 18, 2020

Aethlon Medical To Release Fourth Quarter Financial Results and Host Conference Call on June 25, 2020

PR Newswire June 16, 2020

Aethlon Announces Issuance of European Patent for the Hemopurifier® in Cancer

PR Newswire March 24, 2020

Securities and Exchange Commission (SEC) Order for Halt in trading of Aethlon Medical Stock Expires

PR Newswire February 24, 2020

Aethlon Medical Announces Third Quarter Financial Results and Provides Corporate Update

PR Newswire February 10, 2020

Securities and Exchange Commission (SEC) Order for Halt in trading of Aethlon Medical (NASDAQ:AEMD) Stock

PR Newswire February 10, 2020

Aethlon Medical To Release Third Quarter Financial Results and Host Conference Call on February 10, 2020

PR Newswire February 6, 2020

Agencies Expect Possible Treatments and Hope for a Coronavirus Vaccine as Soon as Three Months

Livemoney January 30, 2020

Aethlon Medical Announces Completion of $3.77 Million Registered Direct Offering

PR Newswire January 22, 2020

Researchers Say Flu Vaccines May Shrink Tumors and Aid in Treating Cancer

Livemoney January 22, 2020